SEARCH
Toggle navigation
HOME
COMPANY
TECHNOLOGY
IMMUNOBODY
MODITOPE
AVIDIMAB
SCIENTIFIC PAPERS & POSTERS
PRODUCTS
PRODUCT PIPELINE
SCIB1
SCIB2
Modi-1
Modi-2
INVESTORS
COMPANY PROFILE
ADVISORS
CORPORATE GOVERNANCE
DOCUMENTS & PRESENTATIONS
SHARE INFO
FINANCIAL INFO
REGULATORY NEWS
REGULATORY NEWS ARCHIVE
NEWS
LATEST NEWS
INTERVIEWS
MEDIA COVERAGE
REGULATORY NEWS
WEBCASTS
YEAR - 2020
YEAR - 2019
YEAR - 2018
YEAR - 2017
YEAR - 2016
YEAR - 2015
CONTACT US
SEARCH
NEWS
LATEST NEWS
HOME
COMPANY
TECHNOLOGY
IMMUNOBODY
MODITOPE
AVIDIMAB
SCIENTIFIC PAPERS & POSTERS
PRODUCTS
PRODUCT PIPELINE
SCIB1
SCIB2
Modi-1
Modi-2
INVESTORS
COMPANY PROFILE
ADVISORS
CORPORATE GOVERNANCE
DOCUMENTS & PRESENTATIONS
SHARE INFO
FINANCIAL INFO
REGULATORY NEWS
REGULATORY NEWS ARCHIVE
NEWS
LATEST NEWS
INTERVIEWS
MEDIA COVERAGE
REGULATORY NEWS
WEBCASTS
YEAR - 2020
YEAR - 2019
YEAR - 2018
YEAR - 2017
YEAR - 2016
YEAR - 2015
CONTACT US
Latest News
SCIB1 IND application approved
To download
click here
Scancell Interim Results
To download
click here
Third agreement signed for antibody platform
To download
click here
Director's Dealings
To download
click here
Second agreement signed for AvidiMab platform
To download
click here
New European Moditope® patent allowed for grant
To download
click here
View all posts
»